Braf in Adjuvant
Research payments
$367,017
Through program year 2020, $367,017 in research payments was reported against Braf in Adjuvant, across 44 payments, paid by Genentech, Inc..
- Paid by
- Genentech, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $1,606 | 2 |
| 2019 | Research | $365,411 | 42 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- David Spigel Nashville, TN Named on 5 payments
- Scott Lunin North Port, FL Named on 5 payments
- Leonel Hernandez Aya Saint Louis, MO Named on 3 payments
- Bradley Somer Memphis, TN Named on 3 payments
- Robert Conry Birmingham, AL Named on 3 payments
- Frederic Kass Santa Barbara, CA Named on 2 payments
- April Salama Chicago, IL Named on 2 payments
- Branimir Sikic Stanford, CA Named on 2 payments
- Omid Hamid Santa Monica, CA Named on 2 payments
- Antoni Ribas Los Angeles, CA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.